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ABSTRACT
Background In atherosclerotic internal carotid artery
(ICA) or middle cerebral artery (MCA) disease, selective
neuronal damage can be detected as a decrease in
central benzodiazepine receptors (BZRs) in the normal-
appearing cerebral cortex. This study aimed to determine
whether a decrease in the BZRs in the non-infarcted
cerebral cortex is associated with poor performance on
the Wisconsin Card Sorting Test (WCST), which
assesses executive functions.
Methods The authors measured the BZRs using positron
emission tomography and
11C-ﬂumazenil in 60 non-
disabled patients with unilateral atherosclerotic ICA or
MCA disease and no cortical infarction. Using three-
dimensional stereotactic surface projections, the
abnormally decreased BZR index (extent (%) of pixels
with Z score >2 compared with controls3average Z
score in those pixels) in the cerebral cortex of the
anterior cerebral artery (ACA) or MCA territory was
calculated and found to be correlated with the patient’s
score on the WCST.
Results On the basis of the WCST results, 39 patients
were considered abnormal (low categories achieved) for
their age. The BZR index of the ACA territory in the
hemisphere affected by arterial disease was signiﬁcantly
higher in abnormal patients than in normal patients. The
BZR index of the MCA territory differed signiﬁcantly
between the two groups when patients with left arterial
disease (n¼28) were analysed separately.
Conclusions In atherosclerotic ICA or MCA disease,
selective neuronal damage that is manifested as
a decrease in BZRs in the non-infarcted cerebral cortex
may contribute to the development of executive
dysfunction.
INTRODUCTION
Imaging of the central benzodiazepine receptors
(BZRs), which are expressed on most cortical
neurons, has made it possible to visualise in vivo
the neuronal alterations induced by ischaemia in
humans.
1e6 Previous studies have shown that in
atherosclerotic internal carotid artery (ICA) or
middle cerebral artery (MCA) disease, haemody-
namic cerebral ischaemia induces selective neuronal
damage manifested as a decrease in BZRs in the
non-infarcted cerebral cortex.
7e9 In patients with
chronic haemodynamic compromise, the perfusion
may fall below the penumbra threshold for
a matter of minutes, causing selective neuronal
damage without any infarction visible on a MRI
scan.
7e9 However, the impact of this type of
damage on clinical outcomes is unclear. In patients
with atherosclerotic ICA or MCA disease, a few
patients with reduced BZRs in the cortex overlying
subcortical infarcts have been reported to show
aphasia,
21 0and a decrease in cortical BZRs has
been shown to be correlated with atrophy of the
corpus callosum that is associated with global
cognitive impairment.
11 12 However, the relation-
ship between a decrease in BZRs and the neuro-
logical symptoms has not been systematically
investigated.
Selective neuronal damage may contribute to
the development of subtle poststroke cognitive
impairment, depending on the degree of neuronal
damage.
13 14 Executive dysfunction may be an early
sign of vascular cognitive impairment and may
have considerable impact on the functional outcomes
of patients with stroke.
15 16 The Wisconsin Card
Sorting Test (WCST) is a widely used clinical test
for assessing executive functions.
17 The goal of
this study was to determine whether a decrease in
BZRs in the non-infarcted cerebral cortex is asso-
ciated with poor performance on the WCST in
patients with atherosclerotic ICA or MCA disease.
METHODS
Patients
We studied 60 consecutive right-handed patients
with unilateral atherosclerotic occlusion or stenosis
of the ICA or MCA (table 1). They were referred to
our positron emission tomography (PET) unit
during 16 months for evaluation of the haemo-
dynamic effects of ICA or MCA disease as a part of
a comprehensive clinical evaluation to determine
the necessity of vascular reconstruction surgery
(carotid endarterectomy, carotid stenting, or
superﬁcial temporal artery to MCA anastomosis).
Inclusion criteria were as follows: (1) occlusion or
stenosis of the ICA (>60% diameter reduction
according to the NASCETcriteria) or MCA (>50%
diameter reduction) as documented by conven-
tional or magnetic resonance angiography
(MRA);
18 19 (2) ability to independently carry out
daily life activities (score on modiﬁed Rankin scale
<3); and (3) for patients with symptoms, history of
transient ischaemic attack (TIA) or completed
stroke involving the relevant ICA or MCA territory.
TIA was deﬁned as the development of focal
symptoms of presumed ischaemic cerebrovascular
origin lasting <24 h. The exclusion criteria were (1)
cortical infarction detectable on routine MRI
images (T1-weighted, T2-weighted or ﬂuid-attenuated
inversion recovery (FLAIR) images); (2) history
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Research paperof TIA or stroke in regions other than the relevant ICA or MCA
territory; (3) history of vascular reconstruction surgery; (4)
contralateral ICA or MCA stenosis (>50%); (5) unilateral arterial
disease with extensive white-matter lesions in both hemi-
spheres; (6) history of consumption of BZR agonists or alcohol
abuse; or (7) presence of potential sources of cardiogenic
embolism, including recent myocardial infarction (<3 weeks
previously), known atrial ﬁbrillation, mitral stenosis, presence of
a prosthetic mitral valve, dilated cardiomyopathy, sick sinus
syndrome or acute bacterial endocarditis.
In the 36 patients with symptoms, the interval between the
last ischaemic event and the PETevaluation ranged from 0.5 to
41 (mean (SD), 8 (10)) months for the 14 TIA patients and from
0.7 to 92 (17 (25)) months for the 22 patients with stroke. In the
24 asymptomatic patients, arterial disease was suspected
because of the ﬁndings of MRA or echoangiography performed
for dizziness, vertigo or loss of consciousness, or as part of
screening for cerebral arterial disease concomitant with coronary
arterial disease.
To obtain a normal control database for BZR imaging, we
studied 10 healthy control subjects (aged 57 (7) years, including
seven men), who had no previous history of medical or
psychiatric disorders and no history of consumption of BZR
agonists or alcohol abuse. The ethics committee of our centre
approved the study protocol, and written informed consent was
obtained from both patients and control individuals.
Wisconsin Card Sorting Test
TheWCSTisoneofthemostfrequentlyusedneuropsychological
tests and is the most sensitive to frontal-lobe dysfunction.
17 In
this study, we used the KeioeFukuokaeShimane version of the
WCST,speciﬁcally,the Keio version of thenewly modiﬁed WCST
that can be performed on a personal computer (PC).
20 21 In this
test, four stimulus cards were shown in the upper row of the PC
test screen, and 48 response cards were shown in order in the
lower row. By trial and error, the participants determined which
stimulus card matched each response card, based on one of the
three categories of colour, form and number selected by the
computer. Simultaneously, the patients were requested to state
which category they selected to evaluate impaired verbal regu-
lation. The computer responded to the answer by voice with
‘correct’ or ‘wrong.’ Once the subject learnt to sort by one rule,
aftersixconsecutivecorrectresponses,theinitialsortingprinciple
was changed without warning, shifting to a new category. The
test continued until all 48 cards were used. The calculated indices
included categories achieved, total errors, perseverative errors as
deﬁned by Nelson, non-perseverative errors and difﬁculty main-
taining sets. Perseverative errors designated exact repetitions of
the immediately preceding incorrect responses, whereas non-
perseverative errors included all errors other than perseverative
errors. Difﬁculty maintaining sets designated incorrect responses
after two or more consecutive correct responses. For the
categories-achieved index, a value of 3 or more for subjects aged
$65 yearsoldandavalueof4ormoreforsubjectsaged#64 years
old was determined to be normal.
21
Positron emission tomography measurements
We performed PET scans using a whole-body Advance scanner
(General Electric Medical System, Milwaukee, Wisconsin),
which permits simultaneous acquisition of 35 image slices with
interslice spacing of 4.25 mm.
22 A transmission scan was
performed using
68Ge/
68Ga for attenuation correction in each
subject before the tracer administration. In reconstruction of
PET data using ﬁltered back projection, images were blurred to
6.0 mm full width at half maximum in the transaxial direction
using a Hanning ﬁlter.
First, a series of
15O-gas studies was performed.
22 C
15O2
and
15O2 were continuously inhaled through a mask. The one
scan time was 5 min. Bolus inhalation of C
15O with scanning
for 3 min was used to measure the cerebral blood volume (CBV).
Arterial blood was sampled two or three times during each
procedure of the
15O-gas study. After the
15O-gas study, a
11C-
ﬂumazenil (FMZ) study was performed.
72 31 1 C-FMZ was
synthesised by
11C-methylation of demethylated-FMZ (Hoff-
mann-La Roche, Basel, Switzerland). Speciﬁc activities at the
time of injection ranged from 16.2 to 20.2 (mean 17.8) GBq/
mmol. After slow intravenous injection of 370e555 MBq of
11C-
FMZ into the right antecubital vein using an automatic injector
over 60 s, a 50 min dynamic PETscan was started at the time of
tracer administration with frame durations of 10 s36, 15 s38,
30 s34, 60 s35, 5 min34 and 10 min32.
We calculated the cerebral blood ﬂow (CBF), cerebral metabolic
rate of oxygen (CMRO2) and oxygen extraction fraction (OEF)
using the steady-state method.
24 The CMRO2 and OEF were
corrected on the basis of the CBV.
25 The binding potential (BP) of
11C-FMZ was calculated using dynamic data and Logan graphical
analysis with reference tissue, in which the pons was used as
a reference region.
23 26 We selected two tomographic planes
corresponding to the pons on the average tissue activity image
obtained from the early phase of dynamic PET data with time
frames of 1e3 min. We manually placed on these two planes an
irregular region of interest (ROI) which included almost all of the
pixels that had activity in the range from the maximum pixel
value to 50% of the maximum value. This method was validated
using the data on normal volunteers in comparison with identi-
ﬁcationoftheponsonacoregistered MRI,
23althoughitisidealto
set the ROIs on the coregistered MRI images in each patient.
These ROIs were transferred to the dynamic PET data for the
creation of parametric images of FMZ BP.
Table 1 Patient characteristics
Characteristics
No of patients (n) 60
Age (mean6SD, years) 6469
Sex, male/female (n) 45/15
Diagnosis (n)
Asymptomatic 24
Transient ischaemic attack 14
Stroke 22
Subcortical infarction (n) 45
Frontal infarction (n) 31
ICA, stenosis (L/R) (n) 23 (9/14)
ICA, occlusion (L/R) (n) 20 (12/8)
MCA, stenosis (L/R) (n) 5 (2/3)
MCA, occlusion (L/R) (n) 12 (5/7)
Conventional angiography (n) 44
Wisconsin Card Sorting Test parameters (n)
Categories achieved 2.461.8
Total errors 24.268.8
Perseverative errors (Nelson) 8.467.7
Non-perseverative errors 15.765.2
Difﬁculty maintaining sets 2.162.0
ICA, internal carotid artery; L/R, left/right; MCA, middle cerebral artery.
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We performed MRI using a Signa unit (General Electric,
Milwaukee, Wisconsin) operated at a ﬁeld strength of 1.5 T. The
imaging protocol consisted of a T2-weighted spin echo (repeti-
tion time/echo time ((TR/TE)¼3000/88.8 ms), T1-weighted
spin echo (TR/TE¼550/11.2 ms) and FLAIR (TR/TE¼8002/
158 ms, inversion time¼2000 ms) imaging series. The slice
thickness was 5 mm, and the intersection gap was 2.5 mm.
Cerebral ischaemic lesions were identiﬁed as hyperintense
lesions on T2-weighted MR images. FLAIR images were used to
distinguish infarcts from dilated perivascular spaces. On the slice
with the largest area of ischaemic lesions, the largest diameter of
a lesion (A) and the largest diameter perpendicular to A (B) were
measured, and A3B (mm
2) was calculated as an index of the size
of the subcortical ischaemic lesion. The total quantity of
subcortical ischaemic lesions was calculated by summing the
indices for all lesions in the hemisphere affected by arterial disease.
A single investigator who was blinded to the clinical status of
the patients, including other imaging data, reviewed all scans.
Data analysis
A three-dimensional stereotactic surface projection (3D-SSP)
technique was used to analyse FMZ BP, CBF and CMRO2
parametric data.
27 Analysis by 3D-SSP anatomically normalises
the individual PET data to the standard brain and compares the
regional voxel data between patients and controls. This proce-
dure was performed using the interface software iSSP (version
3.5; Nihon Medi-Physics Corporation, Nishinomiya, Japan). In
brief, stereotactic reorientation of each brain into a standard
shape is conducted using non-linear warping with the anterior
commissureeposterior commissure line as the anatomic line of
reference. The data are extracted by projecting the cortical
activity onto the brain surface. In the standard stereotactic
system, pixels located on the outer and medial surfaces of both
hemispheres are predetermined along with 3D vectors perpen-
dicular to the surface at each pixel. For each predetermined
surface pixel, the algorithm searches for the highest pixel value
in a direction inward along the vector to a 6-pixel depth into the
cortex in an individual’s anatomically standardised PET image
set and assigns the maximum value to the surface pixel.
Therefore, each brain was stereotactically transformed into
a standard surface image format, which enabled us to compare
the resultant cortical projections between the patients and
controls. This 3D-SSP surface projection technique minimises
the effects of cortical atrophy. For analysis of FMZ BP data, to
negate the effect of ﬂuctuations in whole-brain values and to
extract changes caused by ICA or MCA disease, the pixel values
of an individual’s image set were normalised to the mean cere-
bellar value before the analysis. To quantify the decrease in FMZ
BP, pixel-by-pixel Z scores were used, and Z scores ((mean
normalised pixel value for controlsenormalised pixel value for
each patient)/SD for controls) were calculated for each surface
pixel. A positive Z score relative to the controls represents
a reduced FMZ BP in the patients. We considered Z scores >2t o
be abnormal. To quantitatively assess the degree of FMZ BP
reduction in each patient, the abnormally decreased BZR index
(extent (%) of pixels with Z scores >2 compared with controls
3 average Z score in those pixels) in the cerebral cortex of the
MCA, anterior cerebral artery (ACA) or posterior cerebral artery
(PCA) territory was calculated using the stereotactic extraction
estimation (SEE) method.
28 According to the Talairach Daemon,
anatomical information was segmented into the gyrus level.
Because vascular territories vary among individuals, we
arbitrarily determined the MCA, ACA or PCA territories
according to the atlas prepared by Kretschmann and Weinrich.
29
The MCA territory included the middle and inferior frontal gyri;
precentral gyrus; superior and inferior parietal gyri; angular
gyrus; postcentral gyrus; supramarginal gyrus; superior, middle,
inferior and transverse temporal gyri; and superior and middle
occipital gyri. The ACA territory included the superior and
medial frontal gyri, orbital gyrus, rectal gyrus, paracentral
lobule, subcallosal gyrus, orbital gyrus, precuneus, and cingulate
and anterior cingulate gyri. The PCA territory included the
inferior occipital gyrus, cuneus, fusiform gyrus, lingual gyrus,
parahippocampal gyrus, posterior cingulated gyrus and uncus.
For the analysis of CBF and CMRO2 data, absolute values for
each territory were calculated using the 3DSSP and SEE
methods. The regional value of OEF was recalculated using the
regional values of CBF, CMRO2 and the arterial oxygen content.
Statistical analysis
Hemispheric differences in PET parameters in the three arterial
territories were tested using a paired t test; signiﬁcance was
established at p<0.05. We compared the values of PETor clinical
variables between WCST-abnormal (low categories achieved for
their age) and normal groups using the ManneWhitney U test
or Fisher exact test, as appropriate; signiﬁcance was established
at p<0.05. Correlations between the total number of errors in
the WCSTand the BZR index for the subregions in the MCA or
ACA territory of the affected hemisphere were analysed using
multiple regression analysis after controlling for the effect of the
patient’s age; signiﬁcance was established at p<0.005.
RESULTS
The BZR index, CBF, CMRO2 and OEF of the hemisphere
affected by arterial disease were signiﬁcantly different from
those of the non-affected hemisphere for the MCA and ACA
territories (table 2), whereas hemispheric differences in the
values of the BZR index, CBF, CMRO2 and OEF were not
signiﬁcant for the PCA territory. On the basis of these results,
Table 2 Positron emission tomography results for hemispheres
affected or unaffected by arterial disease
Affected Non-affected
Benzodiazepine receptor index (%)
MCA 30.7630.6* 13.0612.3
ACA 16.0616.5* 12.3613.2
PCA 13.4612.4 11.1610.6
Cerebral blood ﬂow (ml/100 g/min)
MCA 43.468.1* 46.368.4
ACA 45.969.4* 47.069.4
PCA 48.469.4 49.069.4
Cerebral metabolic rate of oxygen (ml/100 g/min)
MCA 3.6560.41* 3.7960.41
ACA 3.7560.48* 3.8160.52
PCA 4.0860.46 4.1360.43
Oxygen extraction fraction (%)
MCA 49.666.6* 48.265.9
ACA 48.666.9* 47.966.8
PCA 48.765.9 48.865.8
Values are mean6SD.
Comparative values for CBF, CMRO2 and OEF in the MCA, ACA and PCA distributions in
normal volunteers were 52.566.0, 50.966.3, 60.367.1, 4.0760.42, 3.8060.40,
4.7060.64, 44.863.4, 43.263.0 and 44.963.6, respectively.
*p<0.05, paired t test.
ACA, anterior cerebral artery; MCA, middle cerebral artery; PCA, posterior cerebral artery.
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MCA and ACA territories for the analyses described below. The
value of the BZR index was signiﬁcantly correlated with the
value of the OEF in the MCA (Spearman, r¼0.32, p<0.05) or
ACA (r¼0.29, p<0.05) territory as well as with the value of the
CBF or CMRO2 in the MCA (r¼ 0.36, p<0.01 or r¼ 0.51,
p<0.001, respectively) or ACA (r¼ 0.38, p<0.005 or r¼ 0.28,
p<0.05) territory. Comparing patients with ICA and MCA
disease, the BZR index in the MCAterritory tended to be high in
patients with MCA disease (ICA/MCA, mean (SD), 26.0 (22.9)/
42.5 (43.2)), and the BZR index in the ACA territory tended to
be high in patients with ICA disease (ICA/MCA, 17.7 (17.8)/
11.9 (12.3)), but these differences were not statistically signiﬁ-
cant (ManneWhitney U test).
For the categories-achieved index of the WCST, 39 patients
were considered abnormal (low categories achieved) for their
age. When we compared the values of the BZR index for the
MCA and ACA territories between the abnormal and normal
groups, the BZR index for the ACA territory was signiﬁcantly
increased in the abnormal group (ﬁgure 1), whereas the BZR
index for the MCA territory tended to be increased in the
abnormal group; these values were not statistically signiﬁcant
(table 3). The patient age, patient sex, side of arterial disease,
incidence of patients with symptoms, incidence or size of
subcortical infarctions, incidence of frontal infarctions, and the
CBF and CMRO2 for the MCA or ACA territories were not
signiﬁcantly different between the abnormal and normal groups.
When we separately analysed the data in patients with left
arterial diseases, the BZR indices for both the ACA and MCA
territories were signiﬁcantly increased in the abnormal group, as
compared with the normal group (table 4). A separate analysis of
the data in patients with ICA or MCA disease (table 5) or in
symptomatic or asymptomatic patients (table 6) yielded results
similar to those of the overall analysis, although the signiﬁcant
difference in the BZR index for the ACA territory disappeared in
patients with ICA disease and in asymptomatic patients.
The total number of errors was signiﬁcantly correlated with
patient age (linear regression analysis, r¼0.39, p¼0.0016), but it
was not signiﬁcantly correlated with the quantity of subcortical
ischaemic lesions (r¼0.07, p¼0.59). Among the BZR indices for
the subregions of the ACA territory, those of the anterior
cingulate gyrus (p¼0.0008) (ﬁgure 2) and the medial frontal
gyrus (p¼0.0012) were signiﬁcantly and positively correlated
with the total number of errors after controlling for the effect of
age by using multiple regression analysis. In patients with left
arterial diseases, among the BZR indices for the subregions of
the MCA territory, the BZR index of the middle frontal gyrus
(p¼0.0015) was signiﬁcantly and positively correlated with the
total number of errors after controlling for the effect of age in
addition to those of the anterior cingulate gyrus (p¼0.0005) and
the medial frontal gyrus (p¼0.0001).
Figure 1 Examples of positron
emission tomography images for
a patient with left (L) internal carotid
artery occlusion. This patient presented
with transient ischaemic attacks, and
the total number of errors on the
Wisconsin Card Sorting Test was 48 (no
correct responses). Angiography
showed collateral pathways through
leptomeningeal anastomosis from the
left posterior cerebral artery and
hypoplasia of the A1 segment of the
right (R) anterior cerebral artery. Upper
row: a decrease in the ﬂumazenil-binding
potential (FMZ-BP), cerebral blood ﬂow
(CBF) and cerebral metabolic rate of
oxygen (CMRO2) was observed in the
bilateral anterior frontal regions. An
increase in the oxygen extraction
fraction (OEF) was observed in the left
frontal region where small subcortical ischemic lesions were found on the corresponding MRI. Lower row: Z score maps from a three-dimensional
stereotactic surface-projection (3DSSP) analysis showing a decrease in the FMZ-BP in the bilateral medial and lateral anterior frontal regions. The
benzodiazepine receptor (BZR) index was 61.5 for the left anterior cerebral artery distribution.
Table 3 Characteristics of abnormal patients (low categories achieved
on Wisconsin Card Sorting Test (WCST)) and normal patients
Abnormal Normal
No of patients (n) 39 21
Benzodiazepine receptor index (%)
MCA territory (affected) 33.8631.4 24.9628.7
ACA territory 19.1616.9* 10.4614.6
Cerebral blood ﬂow (ml/100 g/min)
MCA territory 42.667.7 45.068.8
ACA territory 45.268.5 47.1610.4
Cerebral metabolic rate of oxygen (ml/100 g/min)
MCA territory 3.5860.38 3.7960.44
ACA territory 3.7060.40 3.8560.60
Age (years) 65686 1 610
Sex, male/female (n) 28/11 17/4
Arterial disease, internal carotid artery/
MCA (n)
28/11 15/6
Side of disease, left/right (n) 19/20 9/12
Symptomatic (n) 23 13
Subcortical infarction (n) 31 14
Size (mm
2) 1376194 1426208
Frontal infarction (n) 21 10
Wisconsin Card Sorting Test parameters (n)
Categories achieved 1.461.0* 4.161.0
Total errors 28.667.3* 15.964.2
Perseverative errors (Nelson) 11.168.2* 3.563.0
Values are mean6SD.
*p<0.05, ManneWhitney U test.
ACA, anterior cerebral artery; MCA, middle cerebral artery.
J Neurol Neurosurg Psychiatry 2011;82:150e156. doi:10.1136/jnnp.2010.207274 153
Research paperDISCUSSION
This study showed that selective neuronal damage manifested
as a decrease in the BZRs in the non-infarcted cerebral cortex is
associated with poor performance on the WCST in the non-
disabled patients with unilateral atherosclerotic ICA or MCA
disease and no cortical infarction. The BZR index of the ACA
territory in the hemisphere affected by arterial disease was
signiﬁcantly higher in WCST-abnormal (low categories achieved
for their age) patients than in WCST-normal patients, whereas
the BZR index of the MCA territory was signiﬁcantly different
between the two groups when patients with left arterial disease
were separately analysed.
This study included ICA and MCA diseases, which may have
different impacts on CBF in the ACA territory. Twelve of the 17
studied patients with MCA disease had occlusion of the MCA, in
which blood ﬂowing through the ACA is redistributed via the
leptomeningeal vessels to compensate for the reduced ﬂow in the
MCA, resulting in reduced ﬂow in the ACAterritory.
30 Therefore,
reduced ﬂow can cause selective neuronal damage in the ACA
territory as well as the MCAterritory in both patients with MCA
disease and ICAdisease. The difference in the BZR indexbetween
the hemisphere affected by arterial disease and the non-affected
hemisphere was found in the ACA and MCA territories only,
indicating that the change in the territory of BZRs was primarily
in the area of the affected artery (ICA/MCA). Furthermore,
adecrease intheBZRswasassociated withanincrease intheOEF
in the ACA and MCA territories of the affected hemisphere,
suggesting that selective neuronal damage may be related to
haemodynamic compromise because of ICA or MCA disease.
7
Thus,themajorﬁndingofthepresentstudywasthatthisdecrease
in the BZRs in the ACA and MCAterritories due to ICA or MCA
disease was associated with poor performance of the WCST.
The association of cortical neuronal damage in the ACA
territory with poor performance on the WCST is consistent
with the results of previous studies.
31e36 The WCSTassesses the
executive functions, which are primarily mediated through the
frontal lobes, although an extensive neural network inﬂuences
the performance on the WCST.
31e33 Among patients with single
focal lesions, patients with lesions in the superior medial frontal
lobe, which is included in the ACA territory, were reported to
have the most severely impaired WCST measures.
34 Functional
neuroimaging studies have suggested the role of the medial
frontal cortex in performance monitoring, leading to perfor-
mance adjustments in subsequent trials.
35 Among the medial
frontal regions, the anterior cingulate cortex may be engaged in
the implementation of attentional control that is involved in the
WCST.
33 Lesions in the anterior cingulate sulcus cortex in non-
human primates impair active reference to recent choice
outcomes during rule-based decision-making,
36 which may be
the primary reason for the increase in both perseverative and
non-perseverative errors in the patients studied.
The association of cortical neuronal damage in the MCA terri-
tory with poor performance on the WCST was apparent in
patients with left arterial disease. The WCST method usedin this
study needs verbal mediation during the performance. Therefore,
the language-related left hemisphere may contribute more than
the right hemisphere to the performance of the WCSTused here.
Among subregions in the MCA territory, the mid-dorsolateral
prefrontalregion(therostralpartofthemiddlefrontalgyrus)may
be engaged in monitoring the information in the working
memory, which is essential for performance on the WCST.
36
Cognitive set shifting is mediated by this region, and a lesion in
this region may lead to an increase in perseverative errors.
31e33
Table 4 Characteristics of patients with left and right arterial disease
Left Right
Abnormal Normal Abnormal Normal
No of patients (n) 19 9 20 12
Benzodiazepine receptor index (%)
MCA territory (affected) 17.5612.7* 8.9612.7 49.3636.2 37.0631.9
ACA territory 15.7616.0* 3.765.5 22.2617.6 15.4617.4
Cerebral blood ﬂow (ml/100 g/min)
MCA territory 44.367.5 47.466.9 40.867.8 43.1610.1
ACA territory 46.969.2 50.165.8 43.467.5 44.7612.8
Cerebral metabolic rate of oxygen (ml/100 g/min)
MCA territory 3.7460.35 3.9560.40 3.4160.35 3.6760.46
ACA territory 3.8260.40 3.9660.55 3.5660.37 3.7860.66
Age (years) 63685 8 610 67696 4 69
Sex, male/female (n) 12/7 7/2 16/4 10/2
Arterial disease, internal carotid
artery/MCA (n)
14/5 7/2 14/6 8/4
Symptomatic (n) 11/8 6/3 12/8 7/5
Subcortical infarction (n) 15 6 16 8
Size (mm
2)9 7 698 1556241 1766252 1326191
Frontal infarction (n) 11 5 10 5
Wisconsin Card Sorting Test parameters (n)
Categories achieved 1.261.1* 4.761.0 1.560.9* 4.261.0
Total errors 28.567.3* 15.664.0 28.767.5* 16.164.5
Perseverative errors (Nelson) 11.069.9* 3.062.2 11.366.4* 3.963.5
Values are mean6SD.
*p<0.05, ManneWhitney U test.
Abnormal, low categories achieved on the Wisconsin Card Sorting Test; ACA, anterior
cerebral artery; MCA, middle cerebral artery.
Table 5 Characteristics of patients with internal carotid artery (ICA)
and middle cerebral artery (MCA) disease
ICA MCA
Abnormal Normal Abnormal Normal
No of patients (n) 28 15 11 6
Benzodiazepine receptor index (%)
MCA territory (affected) 24.4624.6 19.7618.4 44.9643.9 38.1645.5
ACA territory 20.2618.3 12.9616.4 16.1613.0* 4.266.2
Cerebral blood ﬂow (ml/100 g/min)
MCA territory 42.866.7 44.967.3 42.0610.4 45.3612.6
ACA territory 44.466.7 45.867.3 47.2612.2 50.3615.9
Cerebral metabolic rate of oxygen (ml/100 g/min)
MCA territory 3.5360.32 3.8160.48 3.7260.51 3.7360.35
ACA territory 3.6060.31 3.8260.61 3.9560.51 3.9460.66
Age (years) 68676 3 611 58665 8 66
Sex, male/female (n) 22/6 12/3 6/5 5/1
Side of disease, left/right (n) 14/14 7/8 5/6 2/4
Symptomatic (n) 15/13 8/7 8/3 5/1
Subcortical infarction (n) 21 10 10 4
Size (mm
2) 1016140 1556238 2316278 1106115
Frontal infarction (n) 13 6 8 4
Wisconsin Card Sorting Test parameters (n)
Categories achieved 1.261.0* 4.261.1 1.761.1* 5.060.6
Total errors 30.666.8* 16.864.0 23.666.3* 13.864.3
Perseverative errors (Nelson) 12.768.5* 4.263.1 7.065.7* 1.861.9
Values are mean6SD.
*p<0.05, ManneWhitney U test.
Abnormal, low categories achieved on the Wisconsin Card Sorting Test; ACA, anterior
cerebral artery; MCA, middle cerebral artery.
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higher than that in the ACA territory, in the patient sample
studied, the association of the BZR index in the MCA territory
with poor performance on the WCSTwas worse than that in the
ACA territory. This may be partly because the regional distribu-
tion of ischaemic damage in the MCA territory in patients with
atherosclerotic ICA or MCA disease may be rather variable.
The BZR index, CBF and CMRO2 reﬂect different aspects of
ischaemic changes in the brain in the case of patients with
atherosclerotic ICA or MCA disease. A decrease in the CBF may
be caused not only by a decrease in perfusion pressure but also
secondarily by a decrease in the CMRO2.
37 A decrease in
CMRO2 is one result of ischaemic damage to the tissue and can
also be caused by a decrease in neural input from distant regions
with ﬁbre connections.
38 Patients with subcortical infarction
may experience a decrease in cortical CMRO2 through deaf-
ferentation of thalamocortical projections that is not accompa-
nied by a decrease in cortical BZRs.
7 As shown in the case of
crossed cerebellar diaschisis, a simple decrease in neural input
may not necessarily be accompanied by apparent neurological
deﬁcits in the target region. In patients with chronic athero-
sclerotic ICA or MCA disease and subcortical infarcts, the BZR
index may most accurately indicate the degree of ischaemic
damage in the target regions among the three variables. This
may explain why the BZR index correlated best with poor
performance on the WCST in the present study, although the
normalisation to the mean cerebellar value and the calculation of
pixel-by-pixel Z scores for the BZR index might have contrib-
uted to the good correlation.
Patients with atherosclerotic ICA or MCA disease and ipsi-
lateral TIA or stroke can have lasting cognitive impairment,
despite the recovery of focal neurological deﬁcits.
39 One of the
causes of this cognitive impairment may be severe, chronic
haemodynamic impairment,
39 40 which may increase the risk of
selective neuronal damage.
7 In some patients with chronic and
potentially reversible global ischaemia and mild neuronal
damage, vascular reconstruction surgery may improve perfusion
and cognitive impairment.
40 41 However, if extensive neuronal
damage occurs, and low perfusion is accompanied by reduced
metabolism, any therapeutic effects of improved perfusion are
mitigated.
40 In patients with stroke with haemodynamic
compromise, intensive treatment for improvement of perfusion
and protection of the neurons should be administered in the
initial stages of infarction to minimise the occurrence of selec-
tive neuronal damage and cognitive impairment, although
a causal relationship between selective neuronal damage and
cognitive impairment should be conﬁrmed during follow-up
studies.
14
This study has some methodological limitations. We could not
perform a correction for partial volume effects, because MRI was
Figure 2 Scatter diagram plotting the benzodiazepine receptor (BZR)
index for the anterior cingulate gyrus for the hemisphere with arterial
disease against the total number of errors on the Wisconsin Card Sorting
Test.
Table 6 Characteristics of symptomatic and asymptomatic patients
Symptomatic Asymptomatic
Abnormal Normal Abnormal Normal
No of patients 23 13 16 8
Benzodiazepine receptor index (%)
MCA territory (affected) 41.1636.4 25.9632.8 23.4619.1 23.4622.6
ACA territory 21.2619.0* 11.0616.8 16.0613.4 9.4611.3
Cerebral blood ﬂow (ml/100 g/min)
MCA territory 40.367.0 44.169.3 45.867.8 46.768.3
ACA territory 43.268.1 46.0610.1 48.168.5 49.4611.4
Cerebral metabolic rate of oxygen (ml/100 g/min)
MCA territory 3.6160.38 3.6160.34 3.5560.49 4.1060.55
ACA territory 3.7460.40 3.6060.36 3.6360.41 4.2960.72
Age (years) 65696 2 611 66666 0 68
Sex, male/female (n) 14/9 10/3 14/2 7/1
Arterial disease, internal carotid artery/
MCA (n)
15/8 8/5 13/3 7/1
Side of disease, left/right (n) 11/12 6/7 8/8 3/5
Subcortical infarction (n) 23 12 8 2
Size (mm
2) 1976225 1826204 52690 766211
Frontal infarction (n) 16 10 5 0
Wisconsin Card Sorting Test parameters (n)
Categories achieved 1.760.9* 4.361.1 0.860.9* 4.761.0
Total errors 28.268.6* 16.464.5 29.265.1* 15.163.7
Perseverative errors (Nelson) 12.469.9* 3.663.4 9.264.2* 3.362.3
Values are mean6SD.
*p<0.05, ManneWhitney U test.
Abnormal, low categories achieved on the Wisconsin Card Sorting Test; ACA, anterior cerebral artery; MCA, middle cerebral artery.
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Research paperstudied only for clinical purposes. To minimise the effect of
cortical atrophy, we used the surface projection technique in
3D-SSP, which is considered to be the best method in this case.
Although we created FMZ-BP parametric maps, the normal-
isationtothemeancerebellarvaluewasneededforthesubsequent
analysis, because interindividual variations of absolute whole-
brain values for FMZ BP were large. To quantitatively assess the
degree of FMZ BP reduction in each patient, we calculated the
BZR index. Although we extracted pixels with Z scores >2a s
abnormal pixels,the issue of multiple comparisons was not taken
into account,andthenewmeasurementoftheBZRindexmaybe
biased. In previous studies, the BZR indexwas shown to be stable
in the sequential evaluations of normal subjects and to be asso-
ciated with haemodynamic compromise in patients with ICA or
MCA disease.
7 In the present study, we showed that the BZR
indexwascorrelatedwithclinicalvariables.Althoughweconsider
the BZR index a useful quantitative measure of decreases in BZR,
further studies should be done to validate it.
In conclusion, in atherosclerotic ICA or MCA disease,
a decrease in BZRs in the non-infarcted cerebral cortex affected
by arterial disease is associated with poor performance on the
WCST. Selective neuronal damage may contribute to the
occurrence of cognitive impairment in patients with athero-
sclerotic ICA or MCA disease.
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